CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the 2017 J.P. Morgan Healthcare Conference to be held at the Westin
St. Francis Hotel in San Francisco, California, on Wednesday, January
11, 2017. The presentation will be delivered by Hany
Massarany, President and Chief Executive Officer, and is scheduled
to begin at 1:30 pm Pacific Time. The presentation will be made
available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated,
multiplex molecular diagnostic testing systems that detect and measure
DNA and RNA targets to diagnose disease and optimize patient treatment.
Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® system is designed to
support a broad range of molecular diagnostic tests with a compact,
easy-to-use workstation and self-contained, disposable test cartridges.
The eSensor detection technology is also incorporated into GenMark's
sample-to-answer system, ePlex®. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161228005001/en/
GenMark Diagnostics, Inc.
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media